Please login to the form below

Not currently logged in
Email:
Password:

Novo Holdings

This page shows the latest Novo Holdings news and features for those working in and with pharma, biotech and healthcare.

Oxford Biomedica gets £53m cash injection from Novo venture arm

Oxford Biomedica gets £53m cash injection from Novo venture arm

John Dawson. “We are delighted that Novo Holdings has become a shareholder in Oxford Biomedica,” said John Dawson, chief executive of Oxford Biomedica. ... Novo Holdings is a well-known and highly regarded long-term investor with significant

Latest news

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    These initiatives have been recently joined by a $165m ‘REPAIR’ fund from Novo Holdings, as an investment in companies involved in discovery and early-stage development of therapies to combat antimicrobial

  • Deal Watch table for February 2014 Deal Watch table for February 2014

    2. and CKD. 3. 198. Zosano (formerly Macroflux) / Novo Nordisk. ... UDG subsidiaries : The Specials Laboratory Holdings, Craig &Hayward, Arjun Products.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Lars Rebien Sørensen becomes chairman of Novo Holdings Lars Rebien Sørensen becomes chairman of Novo Holdings

    He will take up the new role 1 July. Former Novo Nordisk CEO Lars Rebien Sørensen has been appointed as Novo Holdings’ new chairman. ... He said: “In recent years, Novo Holdings has significantly increased its investments and influence in the global

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...

Infographics